N-methyl amisulpride

N/A

Report date: 2026/05/16 20:00:17
NME

Base Information

Drug NameN-methyl amisulpride
Drug Alias NameLB-102homologue of LB-100LB-1.2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonistsDopamine D3 receptor antagonistsSerotonin 7 (5-HT7) receptor antagonists
TargetsDopamine D2 receptorDopamine D3 receptorSerotonin 7 (5-HT7) receptor
Therapy Area/IndicationsBipolar I DisorderSchizophreniaBipolar Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesLb Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesLb Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsBipolar I DisorderSchizophreniaBipolar Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A